Clinical Trial Update: Palbociclib and Sorafenib, Decitabine, or Dexamethasone in Treating Patients With Recurrent or Refractory Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial from MD Anderson tests combinations of palbociclib with sorafenib, decitabine, or dexamethasone in patients with recurrent or refractor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Decitabine (Decitabine)
• Palbociclib (palbociclib)
• Sorafenib (Sorafenib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING